Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide‐co‐glycolide) sintered microsphere scaffolds for bone tissue engineering

Bone tissue engineering offers promising alternatives to repair and restore tissues. Our laboratory has employed poly(lactid‐co‐glycolide) PLAGA microspheres to develop a three dimensional (3‐D) porous bioresorbable scaffold with a biomimetic pore structure. Osseous healing and integration with the surrounding tissue depends in part on new blood vessel formation within the porous structure. Since endothelial cells play a key role in angiogenesis (formation of new blood vessels from pre‐existing vasculature), the purpose of this study was to better understand human endothelial cell attachment, viability, growth, and phenotypic expression on sintered PLAGA microsphere scaffold. Scanning electron microscopy (SEM) examination showed cells attaching to the surface of microspheres and bridging the pores between the microspheres. Cell proliferation studies indicated that cell number increased during early stages and reached a plateau between days 10 and 14. Immunofluorescent staining for actin showed that cells were proliferating three dimensionally through the scaffolds while staining for PECAM‐1 (platelet endothelial cell adhesion molecule) displayed typical localization at cell–cell contacts. Gene expression analysis showed that endothelial cells grown on PLAGA scaffolds maintained their normal characteristic phenotype. The cell proliferation and phenotypic expression were independent of scaffold pore architecture. These results demonstrate that PLAGA sintered microsphere scaffolds can support the growth and biological functions of human endothelial cells. The insights from this study should aid future studies aimed at enhancing angiogenesis in three dimensional tissue engineered scaffolds. Biotechnol. Bioeng. 2007;98: 1094–1102. © 2007 Wiley Periodicals, Inc.

[1]  R. Langer,et al.  Degradation of Poly(Anhydride-Co-Imides): Novel Polymers for Orthopedic Applications , 1995 .

[2]  R. Ian Freshney,et al.  Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications , 2010 .

[3]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[4]  Yasuhiko Tabata,et al.  Effect of the fiber diameter and porosity of non-woven PET fabrics on the osteogenic differentiation of mesenchymal stem cells , 2004, Journal of biomaterials science. Polymer edition.

[5]  C T Laurencin,et al.  Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. , 2004, The Journal of bone and joint surgery. British volume.

[6]  Cato T Laurencin,et al.  The sintered microsphere matrix for bone tissue engineering: in vitro osteoconductivity studies. , 2002, Journal of biomedical materials research.

[7]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .

[8]  C. Laurencin,et al.  Schwannoma of the superficial peroneal nerve presenting as web space pain. , 1995, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[9]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[10]  H. Othmer,et al.  Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.

[11]  Cato T Laurencin,et al.  In vitro bone formation using muscle-derived cells: a new paradigm for bone tissue engineering using polymer-bone morphogenetic protein matrices. , 2003, Biochemical and biophysical research communications.

[12]  Cato T. Laurencin,et al.  Fiber Based Tissue Engineered Scaffolds for Musculoskeletal Applications: in Vitro Cellular Response , 1998 .

[13]  C. Laurencin,et al.  Structural and human cellular assessment of a novel microsphere-based tissue engineered scaffold for bone repair. , 2003, Biomaterials.

[14]  David J. Mooney,et al.  Increased Vascularization and Heterogeneity of Vascular Structures Occurring in Polyglycolide Matrices Containing Aortic Endothelial Cells Implanted in the Rat , 1997 .

[15]  D J Mooney,et al.  Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[16]  C. Laurencin,et al.  Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation. , 1986, Biochemical and biophysical research communications.

[17]  Joyce Bischoff,et al.  Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[18]  L. Hanley,et al.  Preparation and analysis of macroporous TiO2 films on Ti surfaces for bone-tissue implants. , 2001, Journal of biomedical materials research.

[19]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. , 1998, Journal of biomedical materials research.

[20]  Cato T Laurencin,et al.  Tissue engineered microsphere-based matrices for bone repair: design and evaluation. , 2002, Biomaterials.

[21]  Stuart K Williams,et al.  Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. , 2002, Journal of biomedical materials research.

[22]  Cato T Laurencin,et al.  In vitro evaluation of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. , 2006, Biomaterials.

[23]  J. Tomasek,et al.  Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. , 1995, Experimental cell research.

[24]  B. Ratner Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Jeffrey O. Hollinger,et al.  Biomedical applications of synthetic biodegradable polymers , 1995 .

[26]  J. Folkman The vascularization of tumors. , 1976, Scientific American.

[27]  J. A. Cooper,et al.  Tissue engineering: orthopedic applications. , 1999, Annual review of biomedical engineering.

[28]  David J Mooney,et al.  VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  N. Ilan,et al.  PECAM-1: old friend, new partners. , 2003, Current opinion in cell biology.

[30]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[31]  H. DeLisser,et al.  Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. , 2002, American journal of physiology. Cell physiology.

[32]  H R Allcock,et al.  Novel polyphosphazene/poly(lactide-co-glycolide) blends: miscibility and degradation studies. , 1997, Biomaterials.

[33]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[34]  P. J. Newman,et al.  The biology of PECAM-1. , 1997, The Journal of clinical investigation.

[35]  A. Mikos,et al.  Angiogenesis with biomaterial-based drug- and cell-delivery systems , 2004, Journal of biomaterials science. Polymer edition.

[36]  C T Laurencin,et al.  Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices. , 1996, Bone.

[37]  C. Colton,et al.  Implantable biohybrid artificial organs. , 1995, Cell transplantation.

[38]  R. Nadeau,et al.  Liberation of cyclic AMP and catecholamine from the heart during left stellate stimulation in the anesthetized dog. , 1981, Canadian journal of physiology and pharmacology.

[39]  A. U. Daniels,et al.  Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. , 2005, Biomaterials.

[40]  C. Garlanda,et al.  Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.

[41]  C T Laurencin,et al.  Osteoblast-like cell adherance and migration through 3-dimensional porous polymer matrices. , 1995, Biochemical and biophysical research communications.

[42]  Antonios G. Mikos,et al.  Pore Morphology Effects on the Fibrovascular Tissue Growth in Porous Polymer Substrates , 1994, Cell transplantation.

[43]  Robert Langer,et al.  Synthesis and Characterization of Degradable Poly(anhydride-co-imides) , 1995 .

[44]  S. Zigmond,et al.  Signal transduction and actin filament organization. , 1996, Current opinion in cell biology.

[45]  D. Jackson The unfolding tale of PECAM‐1 , 2003, FEBS letters.

[46]  Amit Bandyopadhyay,et al.  Pore size and pore volume effects on alumina and TCP ceramic scaffolds , 2003 .

[47]  K. Burg,et al.  Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.

[48]  Y. Ikada,et al.  Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. , 1999, Journal of biomaterials science. Polymer edition.

[49]  D. Katti,et al.  Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[50]  D. Bullard,et al.  Intercellular Adhesion Molecule-1 (ICAM-1) Regulates Endothelial Cell Motility through a Nitric Oxide-dependent Pathway* , 2004, Journal of Biological Chemistry.

[51]  David J. Mooney,et al.  Promoting Angiogenesis in Engineered Tissues , 2001, Journal of drug targeting.

[52]  C T Laurencin,et al.  Toxicity, biodegradation and elimination of polyanhydrides. , 2002, Advanced drug delivery reviews.

[53]  C. Laurencin,et al.  Polymeric controlled release systems: new methods for drug delivery. , 1987, Clinics in laboratory medicine.

[54]  David J Mooney,et al.  Engineering vascular networks in porous polymer matrices. , 2002, Journal of biomedical materials research.

[55]  C. Laurencin,et al.  Cell-material systems for anterior cruciate ligament regeneration , 1998, In Vitro Cellular & Developmental Biology - Animal.